Source: Υπουργείο Υγείας (CY) Revision Year: 2016 Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Pizogran 0.5 mg film-coated tablets.
Pizogran 1.5 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Pizogran 0.5 mg film-coated tablets: White, round, film-coated tablets with Remedica’s logo on one side. Pizogran 1.5 mg film-coated tablets: White, round, film-coated tablets. |
Pizogran 0.5 mg film-coated tablets: Each film-coated tablet contains pizotifen maleate equivalent to 0.5 mg pizotifen.
Pizogran 1.5 mg film-coated tablets: Each film-coated tablet contains pizotifen maleate equivalent to 1.5 mg pizotifen.
Excipient(s) with known effect:
Pizogran 0.5 mg film-coated tablets: This product contains 32.14 mg lactose.
Pizogran 1.5 mg film-coated tablets: This product contains 96.42 mg lactose.
For the full list of excipients, see section 6.1.
| List of Excipients |
|---|
|
Core: Lactose monohydrate Coating: Hypromellose |
Pizogran 0.5 mg film-coated tablets:
PVC-PVDC/Aluminium blisters. Pack-sizes of 30, 60, 100 and 1000 film-coated tablets.
PP containers with PE closure. Pack-sizes of 100 film-coated tablets.
Pizogran 1.5 mg film-coated tablets:
PVC-PVDC/Aluminium blisters. Pack-sizes of 30, 100 and 1000 film-coated tablets.
PP containers with PE closure. Pack-sizes of 100 film-coated tablets.
Not all pack sizes may be marketed.
Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Pizogran 0.5 mg film-coated tablets: 20191
Pizogran 1.5 mg film-coated tablets: 20192
Pizogran 0.5 mg film-coated tablets:
Date of first authorization: 28 February 2007
Date of latest renewal: 16 January 2013
Pizogran 1.5 mg film-coated tablets:
Date of first authorization: 28 February 2007
Date of latest renewal: 29 March 2013
| Drug | Countries | |
|---|---|---|
| PIZOGRAN | Cyprus |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
